Neeti Kothare, DO
Hospice and Palliative Medicine · Houston, TXNPI 1558898197
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 51 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 10.0% — the pattern of someone who eats at a lot of different presentations. Among hospice and palliative medicine clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 51 payments — averaging $26.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$134
- AstraZeneca$126
- Merck$112
- Regeneron Healthcare Solutions, Inc.$97
- Novartis$73
- GSK$70
- plus $727 from 22 others
What the payments were for
- Food & beverage$1,340100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $134 |
| AstraZeneca(2 entities) | 5 | $126 |
| Merck | 4 | $112 |
| Regeneron Healthcare Solutions, Inc. | 3 | $97 |
| Novartis | 2 | $73 |
| GSK | 3 | $70 |
| Johnson & Johnson | 3 | $69 |
| Bayer | 2 | $51 |
| Geron Corporation | 2 | $46 |
| Tersera Therapeutics LLC | 2 | $45 |
| Jazz Pharmaceuticals Inc. | 2 | $45 |
| Sobi, Inc | 2 | $41 |
| Puma Biotechnology, Inc. | 2 | $37 |
| Legend Biotech USA Inc. | 1 | $37 |
| Sun Pharmaceutical Industries Inc. | 1 | $32 |
| Astellas Pharma US Inc | 1 | $31 |
| Rigel Pharmaceuticals, Inc. | 1 | $30 |
| Daiichi Sankyo Inc. | 1 | $28 |
| Incyte Corporation | 1 | $28 |
| AVEO Pharmaceuticals, Inc. | 1 | $26 |
| Sanofi | 1 | $25 |
| Genmab U.S., Inc. | 1 | $24 |
| Novo Nordisk | 1 | $24 |
| Servier Pharmaceuticals LLC | 1 | $23 |
| Shield Therapeutics Inc | 1 | $22 |
| Cycle Pharmaceuticals Inc | 1 | $22 |
| Eisai Inc. | 1 | $21 |
| Karyopharm Therapeutics Inc. | 1 | $20 |
How this compares
$1,340 in reported general payments places this provider in the 90th percentile of 136 hospice and palliative medicine providers in Texas.
See all hospice and palliative medicine providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fentanyl | 18 | $1,010 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $872 |
| Hydromorphone Hcl | 16 | $825 |
| Morphine Sulfate ErMorphine Sulfate | 17 | $309 |
| Mirtazapine | 12 | $221 |
Paid to pharmacies, not to this prescriber.
Other hospice and palliative medicine in Houston
- Joseph ArthurHouston$19K
- Ishwaria SubbiahHouston$10K
- Akshay ReddyHouston$1K
- Andrea Rodriguez KawasHouston$1K
- Paige FarinholtHouston$877
- Glorymar Lopez GarayuaHouston$867
- Charu AgrawalHouston$467
- Ali HaiderHouston$442
- Angelique WongHouston$392
- Santosh Yatam GaneshHouston$310
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.